Search

Your search keyword '"Lanzillo, Giuseppe"' showing total 4 results
Start Over Author "Lanzillo, Giuseppe" Language undetermined
4 results on '"Lanzillo, Giuseppe"'

1. Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries

Author

Scotti, Andrea, Baggio, Sara, Pagnesi, Matteo, Barbanti, Marco, Adamo, Marianna, Eitan, Amnon, Estévez-Loureiro, Rodrigo, Veulemans, Verena, Toggweiler, Stefan, Mylotte, Darren, De Marco, Federico, Giannini, Francesco, Ferlini, Marco, Naber, Christoph K, Buono, Andrea, Schofer, Joachim, Rottbauer, Wolfgang, Van Mieghem, Nicolas M, Khogali, Saib, Taramasso, Maurizio, Pilgrim, Thomas, Sinning, Jan-Malte, Zweiker, David, Montorfano, Matteo, Van der Heyden, Jan A S, Brugaletta, Salvatore, Ielasi, Alfonso, Hamm, Christian W, Vanhaverbeke, Maarten, Costa, Giuliano, Massussi, Mauro, Alarcón, Robert, Zeus, Tobias, Lunardi, Mattia, Testa, Luca, Di Ienno, Luca, Lanzillo, Giuseppe, Wolf, Alexander, Maffeo, Diego, Ziviello, Francesca, Saccocci, Matteo, Windecker, Stephan, Sedaghat, Alexander, Schmidt, Albrecht, Brouwer, Jorn, Regueiro, Ander, Reimers, Bernhard, Kim, Won-Keun, Sondergaard, Lars, Colombo, Antonio, Mangieri, Antonio, and Latib, Azeem

Subjects
610 Medizin und Gesundheit
Abstract

BACKGROUND In recent years, transcatheter aortic valve replacement (TAVR) techniques and technology have continuously improved. Data regarding the impact of these advancements on outcomes in large real-world settings are still limited. The aim of this study was to investigate temporal trends and assess contemporary outcomes after TAVR with Evolut PRO/PRO+ supra-annular self-expanding valves. METHODS This study included patients enrolled in the multicenter NEOPRO (A Multicenter Comparison of Acurate NEO Versus Evolut PRO Transcatheter Heart Valves) and NEOPRO-2 (A Multicenter Comparison of ACURATE NEO2 Versus Evolut PRO/PRO+ Transcatheter Heart Valves 2) registries who underwent transfemoral TAVR with Evolut PRO/PRO+. Procedural dates (August 2017 through November 2021) were stratified in quartiles (Q) and used to investigate temporal trends in TAVR outcomes. Predischarge, 30-day Valve Academic Research Consortium-3 defined, and 1-year outcomes were evaluated. RESULTS In total, 1616 patients from 28 centers were included. Over time, patients had lower Society of Thoracic Surgeon-Predicted Risk of Mortality score (Q1-4, 4.1% [2.8-6.3%], 3.7% [2.6-5.3%], 3.3% [2.4-4.9%], 2.9% [2.2-4.3%]; P

Published
2023
Full Text
View/download PDF

3. Patent foramen ovale closure through inferior vena cava filter in a patient with deep venous thrombosis and recurrent ischemic events

Author

Marco Ancona, Vittorio Romano, Moreno Tresoldi, Damiano Regazzoli, Giuseppe Lanzillo, Pier Pasquale Leone, Antonio Colombo, Matteo Montorfano, Eustachio Agricola, Akihito Tanaka, Azeem Latib, Antonio Mangieri, Regazzoli, Damiano, Ancona, Marco B., Mangieri, Antonio, Tanaka, Akihito, Romano, Vittorio, Leone, Pier P., Tresoldi, Moreno, Lanzillo, Giuseppe, Agricola, Eustachio, Latib, Azeem, Colombo, Antonio, and Montorfano, Matteo

Subjects
medicine.medical_specialty, Vena Cava Filters, Septal Occluder Device, Inferior vena cava filter, Foramen Ovale, Patent, 030204 cardiovascular system & hematology, Prosthesis Implantation, 03 medical and health sciences, 0302 clinical medicine, Postoperative Complications, Internal medicine, medicine, Secondary Prevention, Humans, 030212 general & internal medicine, Foramen ovale (heart), Aged, Secondary prevention, Vena cava filters, business.industry, Endovascular Procedures, General Medicine, medicine.disease, Surgery, Venous thrombosis, medicine.anatomical_structure, Patent foramen ovale, Cardiology, Female, business, Cardiology and Cardiovascular Medicine, Pulmonary Embolism
Published
2017

4. Percutaneous Direct Annuloplasty With Edge-to-Edge Technique for Mitral Regurgitation: Replicating a Complete Surgical Mitral Repair in a One-Step Procedure

Author

Marco Ancona, Matteo Pagnesi, Francesco Ancona, Azeem Latib, Fabrizio Monaco, Damiano Regazzoli, Antonio Colombo, Paolo Del Sole, Satoru Mitomo, Eustachio Agricola, Antonio Mangieri, Matteo Montorfano, Giuseppe Lanzillo, Ozan M. Demir, Mangieri, Antonio, Colombo, Antonio, Demir, Ozan M., Agricola, Eustachio, Ancona, Francesco, Regazzoli, Damiano, Ancona, Marco B., Mitomo, Satoru, Lanzillo, Giuseppe, Del Sole, Paolo A., Monaco, Fabrizio, Pagnesi, Matteo, Montorfano, Matteo, and Latib, Azeem

Subjects
Male, Cardiac Catheterization, medicine.medical_specialty, Mitral Valve Annuloplasty, Percutaneous, medicine.medical_treatment, Echocardiography, Three-Dimensional, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Mitral valve, Mitral valve annuloplasty, medicine, Humans, Fluoroscopy, cardiovascular diseases, 030212 general & internal medicine, Aged, Cardiac catheterization, Mitral regurgitation, medicine.diagnostic_test, business.industry, MitraClip, Mitral Valve Insufficiency, Combined approach, Surgery, medicine.anatomical_structure, Surgery, Computer-Assisted, cardiovascular system, Mitral Valve, Cardiology and Cardiovascular Medicine, business, Echocardiography, Transesophageal
Abstract

Surgical treatment of functional mitral regurgitation (MR) is usually based on the correction of both annular dilation and leaflet disease to minimize the risk of recurrence of MR at follow-up. This combined approach may also represent an interesting strategy during transcatheter mitral valve repair systems. We report a successful case of combined Cardioband (Edwards Lifesciences, Irvine, California) and MitraClip (Abbott, Santa Clara, California) implantation for the treatment of functional MR, with good acute and medium-term clinical and echocardiographic outcomes. Le traitement chirurgical de l'insuffisance mitrale secondaire (IM) repose généralement sur la correction de la dilatation annulaire et de la maladie des feuillets pour minimiser le risque de récurrence de l'IM durant le suivi. Cette approche combinée peut également représenter une stratégie intéressante durant l'implantation par catheter de dispositifs pour la réparation de la valve mitrale. Nous rapportons le cas d'une implantation réussie de Cardioband (Edwards Lifesciences, Irvine, Californie) et de MitraClip (Abbott, Santa Clara, Californie) dans le traitement d'une IM secondaire, avec de bons résultats cliniques et échocardiographiques à court et à moyen terme.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results